Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV002541733 | SCV003456253 | likely benign | not provided | 2024-12-31 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV004035500 | SCV004930035 | uncertain significance | Inborn genetic diseases | 2023-12-17 | criteria provided, single submitter | clinical testing | The c.4408C>T (p.R1470W) alteration is located in exon 41 (coding exon 41) of the COL7A1 gene. This alteration results from a C to T substitution at nucleotide position 4408, causing the arginine (R) at amino acid position 1470 to be replaced by a tryptophan (W). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |
Natera, |
RCV001280119 | SCV001467272 | uncertain significance | Epidermolysis bullosa dystrophica inversa, autosomal recessive | 2020-10-16 | no assertion criteria provided | clinical testing |